The Hill

European health agency recommends approving Moderna’s combined flu, COVID vaccine

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be granted market authorization in the European Union, marking the first time ...
NPR

Despite U.S. pull out from WHO, reps were (virtually) at the table for big flu confab

For the past week, about 50 flu scientists from around the world were crammed into a conference room at a Hilton hotel in Istanbul, Turkey. Their goal was to design a flu shot that will confer the ...
The Washington Post

Inside RFK Jr.’s push against the flu vaccine that he links to his voice condition

Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
The Conversation

FDA’s abrupt flip‑flop on Moderna’s mRNA flu shot highlights growing risks to drug‑makers of investing in vaccines

Ana Santos Rutschman does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
Wall Street Journal

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA-3.60%decrease; red down pointing triangle application to sell a new seasonal flu shot after the vaccine ...
CBS News

Moderna says FDA will now review its new flu vaccine, reversing earlier decision

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...
Wall Street Journal

How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will ...
CNBC

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...
New York Post

FDA reverses decision not to review Moderna’s new flu vaccine

The Food and Drug Administration has reversed its decision not to review a new flu vaccine from Moderna, the pharmaceutical company said Wednesday. Last week, the FDA sent a missive to Moderna ...
NBC Chicago

Moderna says the FDA will consider its new flu shot after resolving a public dispute

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot.
The Boston Globe

FDA reverses course, will review Moderna flu shot after controversial refusal

The Food and Drug Administration will review Moderna’s new flu vaccine after initially refusing to review the candidate, the Cambridge biotech announced early Wednesday. The FDA’s decision not to ...
The New York Times

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. By Christina Jewett and ...